ADVB — ADVANCED BIOMED Balance Sheet
0.000.00%
- $10.40m
- $7.49m
Annual balance sheet for ADVANCED BIOMED, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.066 | 4.78 | 2.62 | 2.61 | 2.91 |
| Net Total Receivables | 0 | 0.139 | 0.147 | 0.161 | 0.222 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.913 | 5.01 | 2.79 | 3.05 | 6.03 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.093 | 1.23 | 0.954 | 0.651 | 0.397 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.01 | 6.71 | 4.6 | 4.46 | 6.51 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.028 | 2.99 | 3.28 | 2.73 | 2.89 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.03 | 3.22 | 3.29 | 2.8 | 3.03 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.976 | 3.49 | 1.31 | 1.66 | 3.48 |
| Total Liabilities & Shareholders' Equity | 1.01 | 6.71 | 4.6 | 4.46 | 6.51 |
| Total Common Shares Outstanding |